These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 20627566)
21. Synthesis and Th1-immunostimulatory activity of α-galactosylceramide analogues bearing a halogen-containing or selenium-containing acyl chain. Hossain MI; Hanashima S; Nomura T; Lethu S; Tsuchikawa H; Murata M; Kusaka H; Kita S; Maenaka K Bioorg Med Chem; 2016 Aug; 24(16):3687-95. PubMed ID: 27325450 [TBL] [Abstract][Full Text] [Related]
22. Total synthesis of α-1C-galactosylceramide, an immunostimulatory C-glycosphingolipid, and confirmation of the stereochemistry in the first-generation synthesis. Liu Z; Byun HS; Bittman R J Org Chem; 2011 Nov; 76(21):8588-98. PubMed ID: 21958232 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3). Xia C; Yao Q; Schümann J; Rossy E; Chen W; Zhu L; Zhang W; De Libero G; Wang PG Bioorg Med Chem Lett; 2006 Apr; 16(8):2195-9. PubMed ID: 16458002 [TBL] [Abstract][Full Text] [Related]
24. Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cells. Tashiro T; Sekine-Kondo E; Shigeura T; Nakagawa R; Inoue S; Omori-Miyake M; Chiba T; Hongo N; Fujii S; Shimizu K; Yoshiga Y; Sumida T; Mori K; Watarai H; Taniguchi M Int Immunol; 2010 Apr; 22(4):319-28. PubMed ID: 20181652 [TBL] [Abstract][Full Text] [Related]
25. The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy. Taniguchi M; Tashiro T; Dashtsoodol N; Hongo N; Watarai H Int Immunol; 2010 Jan; 22(1):1-6. PubMed ID: 19858073 [TBL] [Abstract][Full Text] [Related]
26. Synthesis of a 2"-deoxy-β-GalCer. Thakur MS; Khurana A; Kronenberg M; Howell AR Molecules; 2014 Jul; 19(7):10090-102. PubMed ID: 25014535 [TBL] [Abstract][Full Text] [Related]
27. Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis. Kaieda S; Tomi C; Oki S; Yamamura T; Miyake S Arthritis Rheum; 2007 Jun; 56(6):1836-45. PubMed ID: 17530712 [TBL] [Abstract][Full Text] [Related]
28. A rapid fluorescence-based assay for classification of iNKT cell activating glycolipids. Arora P; Venkataswamy MM; Baena A; Bricard G; Li Q; Veerapen N; Ndonye R; Park JJ; Lee JH; Seo KC; Howell AR; Chang YT; Illarionov PA; Besra GS; Chung SK; Porcelli SA J Am Chem Soc; 2011 Apr; 133(14):5198-201. PubMed ID: 21425779 [TBL] [Abstract][Full Text] [Related]
29. Total enantioselective synthesis and in vivo biological evaluation of a novel fluorescent BODIPY alpha-galactosylceramide. Vo-Hoang Y; Micouin L; Ronet C; Gachelin G; Bonin M Chembiochem; 2003 Jan; 4(1):27-33. PubMed ID: 12512073 [TBL] [Abstract][Full Text] [Related]
30. The role of iNKT cells in the immunopathology of systemic lupus erythematosus. Gabriel L; Morley BJ; Rogers NJ Ann N Y Acad Sci; 2009 Sep; 1173():435-41. PubMed ID: 19758183 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and human NKT cell stimulating properties of 3-O-sulfo-alpha/beta-galactosylceramides. Xing GW; Wu D; Poles MA; Horowitz A; Tsuji M; Ho DD; Wong CH Bioorg Med Chem; 2005 Apr; 13(8):2907-16. PubMed ID: 15781400 [TBL] [Abstract][Full Text] [Related]
32. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Wilson SB; Delovitch TL Nat Rev Immunol; 2003 Mar; 3(3):211-22. PubMed ID: 12658269 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of 3''- and 4''-deoxy and -fluoro analogs of the immunostimulatory glycolipid, KRN7000. Raju R; Castillo BF; Richardson SK; Thakur M; Severins R; Kronenberg M; Howell AR Bioorg Med Chem Lett; 2009 Aug; 19(15):4122-5. PubMed ID: 19535248 [TBL] [Abstract][Full Text] [Related]
34. Alpha-S-GalCer: synthesis and evaluation for iNKT cell stimulation. Blauvelt ML; Khalili M; Jaung W; Paulsen J; Anderson AC; Brian Wilson S; Howell AR Bioorg Med Chem Lett; 2008 Dec; 18(24):6374-6. PubMed ID: 18993065 [TBL] [Abstract][Full Text] [Related]
35. The in vivo response of invariant natural killer T cells to glycolipid antigens. Parekh VV; Lalani S; Van Kaer L Int Rev Immunol; 2007; 26(1-2):31-48. PubMed ID: 17454263 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of an alpha-C-galactosylceramide analogue that induces Th1-biased responses in human natural killer T cells. Lu X; Song L; Metelitsa LS; Bittman R Chembiochem; 2006 Nov; 7(11):1750-6. PubMed ID: 17009272 [TBL] [Abstract][Full Text] [Related]
37. Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide. Bontkes HJ; Moreno M; Hangalapura B; Lindenberg JJ; de Groot J; Lougheed S; van der Vliet HJ; van den Eertwegh AJ; de Gruijl TD; von Blomberg BM; Scheper RJ Clin Immunol; 2010 Sep; 136(3):364-74. PubMed ID: 20570567 [TBL] [Abstract][Full Text] [Related]
38. RCAI-8, 9, 18, 19, and 49-52, conformationally restricted analogues of KRN7000 with an azetidine or a pyrrolidine ring: Their synthesis and bioactivity for mouse natural killer T cells to produce cytokines. Fuhshuku K; Hongo N; Tashiro T; Masuda Y; Nakagawa R; Seino K; Taniguchi M; Mori K Bioorg Med Chem; 2008 Jan; 16(2):950-64. PubMed ID: 17950609 [TBL] [Abstract][Full Text] [Related]